157 related articles for article (PubMed ID: 20920359)
1. Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein.
De Candia C; Espada C; Duette G; Ghiglione Y; Turk G; Salomón H; Carobene M
Virol J; 2010 Oct; 7():259. PubMed ID: 20920359
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus-1 BF intersubtype recombinant viral protein U second α helix plays an important role in viral release and BST-2 degradation.
De Candia C; Espada C; Duette G; Salomón H; Carobene M
J Gen Virol; 2013 Apr; 94(Pt 4):758-766. PubMed ID: 23223624
[TBL] [Abstract][Full Text] [Related]
3. Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.
Schindler M; Rajan D; Banning C; Wimmer P; Koppensteiner H; Iwanski A; Specht A; Sauter D; Dobner T; Kirchhoff F
Retrovirology; 2010 Jan; 7():1. PubMed ID: 20078884
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu.
Goffinet C; Homann S; Ambiel I; Tibroni N; Rupp D; Keppler OT; Fackler OT
J Virol; 2010 Apr; 84(8):4089-94. PubMed ID: 20147395
[TBL] [Abstract][Full Text] [Related]
5. Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences.
Thomson MM; Delgado E; Herrero I; Villahermosa ML; Vázquez-de Parga E; Cuevas MT; Carmona R; Medrano L; Pérez-Álvarez L; Cuevas L; Nájera R
J Gen Virol; 2002 Jan; 83(Pt 1):107-119. PubMed ID: 11752707
[TBL] [Abstract][Full Text] [Related]
6. Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication.
Soper A; Juarez-Fernandez G; Aso H; Moriwaki M; Yamada E; Nakano Y; Koyanagi Y; Sato K
Exp Biol Med (Maywood); 2017 Apr; 242(8):850-858. PubMed ID: 28346011
[TBL] [Abstract][Full Text] [Related]
7. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV
J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779
[TBL] [Abstract][Full Text] [Related]
8. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
[TBL] [Abstract][Full Text] [Related]
9. Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo.
Yamada E; Nakaoka S; Klein L; Reith E; Langer S; Hopfensperger K; Iwami S; Schreiber G; Kirchhoff F; Koyanagi Y; Sauter D; Sato K
Cell Host Microbe; 2018 Jan; 23(1):110-120.e7. PubMed ID: 29324226
[TBL] [Abstract][Full Text] [Related]
10. The Vpu protein: new concepts in virus release and CD4 down-modulation.
Ruiz A; Guatelli JC; Stephens EB
Curr HIV Res; 2010 Apr; 8(3):240-52. PubMed ID: 20201792
[TBL] [Abstract][Full Text] [Related]
11. Role of HIV-1 Vpu protein for virus spread and pathogenesis.
Nomaguchi M; Fujita M; Adachi A
Microbes Infect; 2008 Jul; 10(9):960-7. PubMed ID: 18672082
[TBL] [Abstract][Full Text] [Related]
12. An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.
Neil SJ; Sandrin V; Sundquist WI; Bieniasz PD
Cell Host Microbe; 2007 Sep; 2(3):193-203. PubMed ID: 18005734
[TBL] [Abstract][Full Text] [Related]
13. Function of human immunodeficiency virus type 1 Vpu protein in various cell types.
Sakai H; Tokunaga K; Kawamura M; Adachi A
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2717-22. PubMed ID: 7595378
[TBL] [Abstract][Full Text] [Related]
14. The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu.
Andrew AJ; Miyagi E; Kao S; Strebel K
Retrovirology; 2009 Sep; 6():80. PubMed ID: 19737401
[TBL] [Abstract][Full Text] [Related]
15. β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.
Tervo HM; Homann S; Ambiel I; Fritz JV; Fackler OT; Keppler OT
Retrovirology; 2011 Feb; 8():9. PubMed ID: 21310048
[TBL] [Abstract][Full Text] [Related]
16. Genetic characterization of natural variants of Vpu from HIV-1 infected individuals from Northern India and their impact on virus release and cell death.
Verma S; Ronsard L; Kapoor R; Banerjea AC
PLoS One; 2013; 8(3):e59283. PubMed ID: 23555649
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the severe CD4+ T-cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate.
Hill MS; Ruiz A; Pacyniak E; Pinson DM; Culley N; Yen B; Wong SW; Stephens EB
Virology; 2008 Feb; 371(1):86-97. PubMed ID: 17950774
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
[TBL] [Abstract][Full Text] [Related]
19. Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages.
Richards KH; Clapham PR
J Gen Virol; 2007 Oct; 88(Pt 10):2780-2792. PubMed ID: 17872532
[TBL] [Abstract][Full Text] [Related]
20. Anti-tetherin activities in Vpu-expressing primate lentiviruses.
Yang SJ; Lopez LA; Hauser H; Exline CM; Haworth KG; Cannon PM
Retrovirology; 2010 Feb; 7():13. PubMed ID: 20167081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
